Weekly Spotlight - 27.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

New Drug Shows Promise in Overcoming Limitations of Older Treatments for Rare Genetic Disorder

Pombiliti and opfolda, new treatments for pompe disease, are showing promise in overcoming the limitations of older enzyme replacement therapies (ERTs), offering potential improvements in patient outcomes and quality of life. These newer treatments aim to address the challenges faced by patients with pompe disease.

New Enzyme Replacement Therapy Shows Promise in Treating Rare Genetic Disorder

Researchers studied the safety and efficacy of a new enzyme replacement therapy for pompe disease, finding it to be well-tolerated and effective in improving muscle function and reducing glycogen levels in patients. The study highlights potential benefits of this treatment for managing the disease.

Trumps Presidency Return: Boom or Bust for Biopharmaceutical Deal Activity?

Researchers studied the safety and efficacy of a new enzyme replacement therapy for pompe disease, finding it to be well-tolerated and effective in improving muscle function and reducing glycogen levels in patients. The study highlights potential benefits of this treatment for managing the disease.